SCHEMBL15212015

SCHEMBL15212015

CCC[n+]1ccc(N2CCCC2)cc1

nearest known ligand 0.59

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CHKA P35790 14/20 0.59
BCHE P06276 1/20 0.58
ACHE P22303 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL15212212 0.98 CHKA (0.58) CHKABCHEACHE
Water SCHEMBL15212784 0.98 CHKA (0.58) CHKABCHEACHE
SCHEMBL15211999 0.89 CHKA (0.56) CHKABCHEACHE
Iodide SCHEMBL15212342 0.88 CHKA (0.59) CHKABCHEACHE
Iodide SCHEMBL15212172 0.87 CHKA (0.54) CHKABCHEACHE
Water SCHEMBL15212777 0.87 CHKA (0.54) CHKABCHEACHE
SCHEMBL9328178 0.86 CHKA (0.61) CHKABCHEACHE
Hydrochloric Acid SCHEMBL9328059 0.84 CHKA (0.59) CHKABCHEACHE
Bromide SCHEMBL9327138 0.84 CHKA (0.65) CHKABCHEACHE
SCHEMBL9329679 0.84 CHKA (0.62) CHKABCHEACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10696560-B2 Small crystal EMM-17, its method of making and use EXXONMOBIL RESEARCH & ENGINEERING COMPANY (US) 2020-06-30 US claimed
US-20190031518-A1 SMALL CRYSTAL EMM-17, ITS METHOD OF MAKING AND USE EXXONMOBIL RES & ENG CO (US) 2019-01-31 US claimed
WO-2019022908-A1 SMALL CRYSTAL EMM-17, ITS METHOD OF MAKING AND USE EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2019-01-31 WO claimed
US-9890050-B2 Molecular sieve material, its synthesis and use EXXONMOBIL CHEMICAL PATENTS INC. (US) 2018-02-13 US claimed
EP-2817262-B1 MOLECULAR SIEVE MATERIAL, ITS SYNTHESIS AND USE EXXONMOBIL CHEMICAL PATENTS INC (US) 2017-11-15 EP claimed
US-20160368778-A1 Molecular Sieve Material, Its Synthesis and Use EXXONMOBIL CHEMICAL PATENTS INC. 2016-12-22 US claimed
US-9452423-B2 Molecular sieve material, its synthesis and use EXXONMOBIL CHEMICAL PATENTS INC. (US) 2016-09-27 US claimed
US-20150025291-A1 Molecular Sieve Material, Its Synthesis and Use EXXONMOBIL CHEMICAL PATENTS INC. 2015-01-22 US claimed
EP-2817262-A1 MOLECULAR SIEVE MATERIAL, ITS SYNTHESIS AND USE ExxonMobil Chemical Patents Inc. (US) 2014-12-31 EP claimed
WO-2013126140-A1 MOLECULAR SIEVE MATERIAL, ITS SYNTHESIS AND USE EXXONMOBIL CHEMICAL PATENTS INC. (US) 2013-08-29 WO claimed
EP-3898901-B1 CATALYTIC DEWAXING OF HYDROCARBON FEEDSTOCKS EXXONMOBIL TECHNOLOGY & ENGINEERING COMPANY (US) 2024-09-11 EP disclosed
CN-113242899-B Catalytic dewaxing of hydrocarbon feedstocks 埃克森美孚科技工程公司 2023-05-30 CN disclosed
EP-3898901-A1 CATALYTIC DEWAXING OF HYDROCARBON FEEDSTOCKS ExxonMobil Research and Engineering Company (US) 2021-10-27 EP disclosed
CN-113242899-A Catalytic dewaxing of hydrocarbon feedstocks 埃克森美孚研究工程公司 2021-08-10 CN disclosed
US-10995286-B2 Catalytic dewaxing of hydrocarbon feedstocks EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2021-05-04 US disclosed
US-20150025291-A1 Molecular Sieve Material, Its Synthesis and Use EXXONMOBIL CHEMICAL PATENTS INC. 2015-01-22 US disclosed
US-20150025291-A1 Molecular Sieve Material, Its Synthesis and Use EXXONMOBIL CHEMICAL PATENTS INC. 2015-01-22 US disclosed
EP-2817262-A1 MOLECULAR SIEVE MATERIAL, ITS SYNTHESIS AND USE ExxonMobil Chemical Patents Inc. (US) 2014-12-31 EP disclosed
WO-2013126140-A1 MOLECULAR SIEVE MATERIAL, ITS SYNTHESIS AND USE EXXONMOBIL CHEMICAL PATENTS INC. (US) 2013-08-29 WO disclosed
WO-2013126140-A1 MOLECULAR SIEVE MATERIAL, ITS SYNTHESIS AND USE EXXONMOBIL CHEMICAL PATENTS INC. (US) 2013-08-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150025291-A1 Molecular Sieve Material, Its Synthesis and Use RPS17, MMP17, MRPS27 CHKA 4726/4885BCHE 4848/4885ACHE 4404/4885
US-20160368778-A1 Molecular Sieve Material, Its Synthesis and Use MMP17, RPS17, CDK17 CHKA 4718/4885BCHE 4850/4885ACHE 4357/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.